Your browser doesn't support javascript.
loading
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma.
Braekeveldt, Noémie; von Stedingk, Kristoffer; Fransson, Susanne; Martinez-Monleon, Angela; Lindgren, David; Axelson, Håkan; Levander, Fredrik; Willforss, Jakob; Hansson, Karin; Øra, Ingrid; Backman, Torbjörn; Börjesson, Anna; Beckman, Siv; Esfandyari, Javanshir; Berbegall, Ana P; Noguera, Rosa; Karlsson, Jenny; Koster, Jan; Martinsson, Tommy; Gisselsson, David; Påhlman, Sven; Bexell, Daniel.
Afiliação
  • Braekeveldt N; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden.
  • von Stedingk K; Department of Clinical Sciences, Division of Pediatric Oncology, Lund University, University Hospital, Lund, Sweden. daniel.bexell@med.lu.se kristoffer.von_stedingk@med.lu.se.
  • Fransson S; Department of Oncogenomics, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Martinez-Monleon A; Department of Pathology and Genetics, University of Gothenburg, Gothenburg, Sweden.
  • Lindgren D; Department of Pathology and Genetics, University of Gothenburg, Gothenburg, Sweden.
  • Axelson H; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden.
  • Levander F; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden.
  • Willforss J; Department of Immunotechnology, Lund University, Lund, Sweden.
  • Hansson K; Department of Immunotechnology, Lund University, Lund, Sweden.
  • Øra I; Department of Immunotechnology, Lund University, Lund, Sweden.
  • Backman T; Department of Clinical Sciences, Division of Pediatric Oncology, Lund University, University Hospital, Lund, Sweden.
  • Börjesson A; Division of Pediatric Surgery, Department of Clinical Sciences, Lund University, University Hospital, Lund, Sweden.
  • Beckman S; Division of Pediatric Surgery, Department of Clinical Sciences, Lund University, University Hospital, Lund, Sweden.
  • Esfandyari J; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden.
  • Berbegall AP; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden.
  • Noguera R; Department of Pathology, Medical School, University of Valencia/INCLIVA/CIBERONC, Madrid, Spain.
  • Karlsson J; Department of Pathology, Medical School, University of Valencia/INCLIVA/CIBERONC, Madrid, Spain.
  • Koster J; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Martinsson T; Department of Oncogenomics, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Gisselsson D; Department of Pathology and Genetics, University of Gothenburg, Gothenburg, Sweden.
  • Påhlman S; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Bexell D; Department of Pathology, Laboratory Medicine, Medical Services, University Hospital, Lund, Sweden.
Cancer Res ; 78(20): 5958-5969, 2018 10 15.
Article em En | MEDLINE | ID: mdl-30154149
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estadiamento de Neoplasias / Transplante de Neoplasias / Neuroblastoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estadiamento de Neoplasias / Transplante de Neoplasias / Neuroblastoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia